Phase I/II clinical trial - Pédiatrie Tumeurs cérébrales
NIVOGLIO
Pédiatrie Tumeurs cérébrales
Essai clinique fermé
Public cible
Enfant
Phase I-II study of nivolumab in combination;with temozolomide and radiotherapy;in children and adolescents;with newly diagnosed high-grade glioma
Description de l'essai
Study evaluating 1) feasibility (number of DLT) , 2) efficacy (EFS at 1 year) of a treatment combining standard (irradiation and temozolomide) immunotherapy by Nivolumab in children and adolescents just operated on for high-grade gliomas supratentoriels (outside the middle line and mutated H3K27)
![FRANCOIS DOZ Vignette](/sites/default/files/styles/carre_petit/public/annuaire/00900198-65685c7e5f20b.jpg?h=78aab1d8&itok=fJAfqmz1)
FRANCOIS DOZ
Investigateur principal